Literature DB >> 12384380

Erythromycin resistance in Borrelia burgdorferi.

Darya Terekhova1, Marina L Sartakova, Gary P Wormser, Ira Schwartz, Felipe C Cabello.   

Abstract

Susceptibility testing of laboratory strains and clinical isolates of Borrelia burgdorferi indicates that resistance to erythromycin is present in them. Evaluation of the MICs, minimal bactericidal concentrations, and kinetics of bacterial killing of erythromycin suggests that this resistance is increased by preexposure to the antibiotic, is dependent on inoculum size, and may be the result of selection of subpopulations of bacterial cells with increased resistance.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384380      PMCID： PMC128697          DOI： 10.1128/AAC.46.11.3637-3640.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Mutations of Bacteria from Virus Sensitivity to Virus Resistance.

Authors:  S E Luria; M Delbrück
Journal:  Genetics       Date:  1943-11       Impact factor: 4.562

Review 3.  Antibiotic treatment in Lyme borreliosis.

Authors:  A Philipson
Journal:  Scand J Infect Dis Suppl       Date:  1991

4.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  The spirochetal etiology of Lyme disease.

Authors:  A C Steere; R L Grodzicki; A N Kornblatt; J E Craft; A G Barbour; W Burgdorfer; G P Schmid; E Johnson; S E Malawista
Journal:  N Engl J Med       Date:  1983-03-31       Impact factor: 91.245

6.  Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.

Authors:  Eliana Drenkard; Frederick M Ausubel
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

7.  rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  J J Schwartz; A Gazumyan; I Schwartz
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

Review 8.  Treatment failure in erythema migrans--a review.

Authors:  K Weber
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

9.  Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

Authors:  R C Johnson; C Kodner; M Russell
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191
View more
  23 in total

1.  Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice.

Authors:  Gary P Wormser; Thomas J Daniels; Susan Bittker; Denise Cooper; Guiqing Wang; Charles S Pavia
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Functional analysis of Borrelia burgdorferi uvrA in DNA damage protection.

Authors:  Mariya Sambir; Larisa B Ivanova; Anton V Bryksin; Henry P Godfrey; Felipe C Cabello
Journal:  FEMS Microbiol Lett       Date:  2011-02-17       Impact factor: 2.742

3.  Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi.

Authors:  Daniel Criswell; Virginia L Tobiason; J Stephen Lodmell; D Scott Samuels
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Screening of a Leptospira biflexa mutant library to identify genes involved in ethidium bromide tolerance.

Authors:  Helena Pětrošová; Mathieu Picardeau
Journal:  Appl Environ Microbiol       Date:  2014-07-25       Impact factor: 4.792

Review 5.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

Review 6.  Genetic Manipulation of Borrelia Spp.

Authors:  Dan Drecktrah; D Scott Samuels
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Authors:  Stephen W Barthold; Emir Hodzic; Denise M Imai; Sunlian Feng; Xiaohua Yang; Benjamin J Luft
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

Review 8.  Sleeper cells: the stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle.

Authors:  Felipe C Cabello; Henry P Godfrey; Julia V Bugrysheva; Stuart A Newman
Journal:  Environ Microbiol       Date:  2017-09-11       Impact factor: 5.491

Review 9.  Tick-borne infections in children: epidemiology, clinical manifestations, and optimal management strategies.

Authors:  Steven C Buckingham
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

10.  Evidence of a conjugal erythromycin resistance element in the Lyme disease spirochete Borrelia burgdorferi.

Authors:  Charlene R Jackson; Julie A Boylan; Jonathan G Frye; Frank C Gherardini
Journal:  Int J Antimicrob Agents       Date:  2007-10-01       Impact factor: 5.283
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.